Warth appointed MD of Instar Europe
Warth (pictured) joins the company from GfK, where she most recently held the role of UK head of health and global business development. Prior client-side and agency experience includes Pfizer and Jigsaw.
Jean-Olivier Marty, group president at Instar, said Warth will be "instrumental" in developing partnerships with pharmaceutical clients.
He added: "Kelly’s intimate knowledge of market research and clients’ needs will allow us to keep providing innovative tracking and testing research, allowing our clients to enhance the performance of their brands."
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments